Abstract

119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call